TR201903887T4 - İnme etkilerini tedavi etme yöntemi. - Google Patents
İnme etkilerini tedavi etme yöntemi. Download PDFInfo
- Publication number
- TR201903887T4 TR201903887T4 TR2019/03887T TR201903887T TR201903887T4 TR 201903887 T4 TR201903887 T4 TR 201903887T4 TR 2019/03887 T TR2019/03887 T TR 2019/03887T TR 201903887 T TR201903887 T TR 201903887T TR 201903887 T4 TR201903887 T4 TR 201903887T4
- Authority
- TR
- Turkey
- Prior art keywords
- treating
- stroke
- effects
- subject
- cells
- Prior art date
Links
- 230000003925 brain function Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
Abstract
Mevcut tarifname, beyin fonksiyonunun iyileştirilmesi veya beyin fonksiyon kaybının önlenmesi ve/veya inme geçirmiş bir denekte bir hareket bozukluğunun tedavi edilmesi veya önlenmesi ve/veya beyin nöronlarının yenilenmesi için yöntemler sağlar, yöntem, deneğe STRO-1+ hücreleri ve/veya bunların soyları ve/veya bunlardan türetilmiş çözünebilir faktörler ile zenginleştirilmiş bir hücre popülasyonunun uygulanmasını içerir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161493057P | 2011-06-03 | 2011-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201903887T4 true TR201903887T4 (tr) | 2019-04-22 |
Family
ID=47258178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/03887T TR201903887T4 (tr) | 2011-06-03 | 2012-06-04 | İnme etkilerini tedavi etme yöntemi. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20160361362A1 (tr) |
EP (2) | EP2714058B1 (tr) |
JP (1) | JP6265890B2 (tr) |
KR (2) | KR101920277B1 (tr) |
CN (2) | CN103826646A (tr) |
AU (2) | AU2012262679B2 (tr) |
CA (1) | CA2837898C (tr) |
ES (1) | ES2716015T3 (tr) |
IL (1) | IL229706A0 (tr) |
SG (1) | SG195128A1 (tr) |
TR (1) | TR201903887T4 (tr) |
WO (1) | WO2012162758A1 (tr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2729562T (pt) | 2011-07-06 | 2018-07-18 | Cell Therapy Ltd | Células progenitoras de linhagem mesodérmica |
WO2019241462A1 (en) * | 2018-06-13 | 2019-12-19 | Texas Tech University System | Stem cells for the treatment of conditions and diseases |
EP3902910A1 (en) * | 2018-12-24 | 2021-11-03 | Selexis S.A. | Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells |
KR20220011621A (ko) * | 2019-05-23 | 2022-01-28 | 메조블라스트 인터내셔널 에스에이알엘 | 뇌경색의 기능적 회복 |
EP4098266A4 (en) * | 2020-01-08 | 2023-07-19 | Foundation for Biomedical Research and Innovation at Kobe | PHYSICAL FUNCTION RECOVERY PROMOTER |
CN118121725A (zh) * | 2022-12-02 | 2024-06-04 | 中国科学院深圳先进技术研究院 | 一种用于评估脑梗死药物疗效的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
WO1992001070A1 (en) | 1990-07-09 | 1992-01-23 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
DE19939781C2 (de) | 1999-08-21 | 2003-06-18 | Schott Glas | Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken |
WO2003026489A2 (en) * | 2001-09-28 | 2003-04-03 | University Of Florida | Biopolymer and biopolymer-cell compositions for nerve tissue repair |
US20080260694A1 (en) | 2004-09-24 | 2008-10-23 | Angioblast Systems, Inc. | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof |
CN101248171B (zh) | 2005-04-12 | 2015-11-25 | 迈索布拉斯特股份有限公司 | 通过组织非特异性碱性磷酸酶分离成人多潜能细胞 |
US20080075345A1 (en) | 2006-09-20 | 2008-03-27 | Siemens Corporation Research, Inc. | Method and System For Lymph Node Segmentation In Computed Tomography Images |
WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
WO2008052046A2 (en) | 2006-10-24 | 2008-05-02 | Case Western Reserve University | Compositions for coating cell membranes and methods of use thereof |
US20090053182A1 (en) | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
US20090232782A1 (en) * | 2008-03-14 | 2009-09-17 | Yu-Show Fu | Method for treating brain ischemic injury through transplantation of human umbilical mesenchymal stem cells |
JP5793724B2 (ja) * | 2008-08-22 | 2015-10-14 | 公益財団法人ヒューマンサイエンス振興財団 | 脳梗塞治療材 |
ES2825723T3 (es) | 2009-07-13 | 2021-05-17 | Biogencell Ltd | Método para utilizar células directoras para la activación y diferenciación de células madre/progenitoras específicas |
KR20130008594A (ko) * | 2010-03-26 | 2013-01-22 | 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 | 손상부 치료용 조성물 |
US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
-
2012
- 2012-06-04 ES ES12793424T patent/ES2716015T3/es active Active
- 2012-06-04 EP EP12793424.8A patent/EP2714058B1/en active Active
- 2012-06-04 TR TR2019/03887T patent/TR201903887T4/tr unknown
- 2012-06-04 CN CN201280033263.1A patent/CN103826646A/zh active Pending
- 2012-06-04 KR KR1020137034971A patent/KR101920277B1/ko active IP Right Grant
- 2012-06-04 KR KR1020187032953A patent/KR20180126607A/ko not_active Application Discontinuation
- 2012-06-04 AU AU2012262679A patent/AU2012262679B2/en active Active
- 2012-06-04 SG SG2013086822A patent/SG195128A1/en unknown
- 2012-06-04 WO PCT/AU2012/000630 patent/WO2012162758A1/en unknown
- 2012-06-04 EP EP18213454.4A patent/EP3513797A1/en active Pending
- 2012-06-04 CN CN202110054916.5A patent/CN112891374A/zh active Pending
- 2012-06-04 CA CA2837898A patent/CA2837898C/en active Active
- 2012-06-04 JP JP2014513005A patent/JP6265890B2/ja active Active
-
2013
- 2013-11-28 IL IL229706A patent/IL229706A0/en unknown
-
2014
- 2014-08-11 US US14/456,534 patent/US20160361362A1/en not_active Abandoned
-
2016
- 2016-08-24 AU AU2016219603A patent/AU2016219603A1/en not_active Abandoned
-
2021
- 2021-03-08 US US17/194,855 patent/US20210228639A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20160361362A1 (en) | 2016-12-15 |
CN103826646A (zh) | 2014-05-28 |
US20210228639A1 (en) | 2021-07-29 |
EP2714058A1 (en) | 2014-04-09 |
EP3513797A1 (en) | 2019-07-24 |
EP2714058B1 (en) | 2018-12-19 |
JP6265890B2 (ja) | 2018-01-24 |
KR101920277B1 (ko) | 2018-11-20 |
CA2837898C (en) | 2020-06-30 |
WO2012162758A1 (en) | 2012-12-06 |
IL229706A0 (en) | 2014-01-30 |
JP2014516715A (ja) | 2014-07-17 |
KR20140068811A (ko) | 2014-06-09 |
CN112891374A (zh) | 2021-06-04 |
AU2016219603A1 (en) | 2016-09-15 |
ES2716015T3 (es) | 2019-06-07 |
KR20180126607A (ko) | 2018-11-27 |
CA2837898A1 (en) | 2012-12-06 |
EP2714058A4 (en) | 2014-12-03 |
AU2012262679A1 (en) | 2013-05-02 |
AU2012262679B2 (en) | 2016-05-26 |
SG195128A1 (en) | 2013-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016219603A1 (en) | Method of treating the effects of stroke | |
MX2016002582A (es) | Metodo para producir celulas progenitoras hepaticas adultas. | |
MX2017002667A (es) | Metodo para producir celulas progenitoras hepaticas adultas. | |
EA201391392A1 (ru) | Синтетические наноносители с осмотически опосредованным высвобождением | |
WO2014035140A3 (en) | Compounds and compositions for modulating histone methyltransferase activity | |
MX2020001258A (es) | Moduladores del factor del complemento b. | |
DOP2013000250A (es) | Composiciones de nucleasa terapeuticas y metodos | |
UA122324C2 (uk) | Терапевтично активні сполуки і способи їх застосування | |
IN2015DN00438A (tr) | ||
MX337193B (es) | Ensambles de soporte de maquina de dialisis y sistemas y metodos relacionados. | |
WO2013124817A8 (en) | MicroRNAS FOR THE GENERATION OF ASTROCYTES | |
MX2013006056A (es) | Metodos para diagnosticar y tratar trastornos relacionados con la longitud del ojo. | |
TW201611843A (en) | Methods of treatment with arginine deiminase | |
WO2012064806A3 (en) | Methods and compositions for unsilencing imprinted genes | |
MX2013012785A (es) | Tratamiento del mieloma multiple. | |
MX369521B (es) | Metodos de creacion de bancos de celulas de alta densidad. | |
MX2012013740A (es) | Metodos para tratar trastornos resistentes al metotrexato con 10-propargil-10-deaza-aminopterina. | |
WO2013022740A3 (en) | Gpr35 ligands and the uses thereof | |
NZ708654A (en) | Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors | |
TN2013000388A1 (en) | Anticoagulant antidotes | |
IN2014DN08385A (tr) | ||
CA2837895C (en) | Methods of treating or preventing neurological diseases | |
SG195170A1 (en) | Methods of treating or preventing rheumatic disease | |
WO2012109267A3 (en) | Novel peptides and methods using same | |
MX2015016062A (es) | Sub-poblacion de monocitos humanos para el tratamiento de enfermedades y trastornos del ojo. |